The treatment of patients at risk of developing Wernicke's encephalopathy in the community.
about
Thiamine for prevention and treatment of Wernicke-Korsakoff Syndrome in people who abuse alcoholSigns of preclinical Wernicke's encephalopathy and thiamine levels as predictors of neuropsychological deficits in alcoholism without Korsakoff's syndromeThe evolution and treatment of Korsakoff's syndrome: out of sight, out of mind?Alcohol-Related Dementia and Neurocognitive Impairment: A Review StudyThiamine deficiency and deliriumAlcohol-related dementia: an update of the evidence.A follow up study on the efficacy of metadoxine in the treatment of alcohol dependence.Diagnosis and management of alcohol use disordersManaging medical and surgical disorders after divided Roux-en-Y gastric bypass surgery.Nutritional deficiencies after bariatric surgery.Time to act on the inadequate management of Wernicke's encephalopathy in the UK.Review article: The nutritional and pharmacological consequences of obesity surgery.Neuropsychological functioning in Wernicke's encephalopathy.Blocking GABA-A receptors in the medial septum enhances hippocampal acetylcholine release and behavior in a rat model of diencephalic amnesia.Treatment of Wernicke's encephalopathy with high dose of thiamine in a patient with pyloric sub-stenosis: description of a case.Korsakoff's syndrome: a critical review.Wernicke's encephalopathy following reduced food intake due to depressive disorders.Thiamin in Clinical Practice.A novel scoring system to guide risk assessment of Wernicke's encephalopathy.
P2860
Q24201415-C65C2688-6F2B-410D-BAEA-A787AB30D121Q24601758-5989843E-7B5E-4D2F-B9F9-8DF4A1A56D87Q24632946-CDA9BB67-08E4-4523-9ACF-C13A2CEFDA05Q28075714-8E9B1653-4D2C-41D9-8409-B31A1E38EFB8Q28688380-B3954F83-34CB-45D1-8115-2E8A910FA80BQ34324208-B5798AEB-DA11-4056-B256-D3E2F589A3B8Q35574880-C8291753-6E23-4E28-8C49-13FDBD9E67A1Q36482464-B33C98B7-E73C-494B-B559-55E6495E8508Q37748488-41577F7D-F044-4CA6-AA38-7E6F7D43AC4EQ38004745-14947E2B-84A1-4DF7-9483-736B56B2B477Q38052042-29B6CF61-A1BD-4B3F-BD55-1AFB77B894A6Q38235543-F28C7B71-875F-4E90-8691-260A02B0E00FQ41840383-FEB45A29-15D1-4798-820B-D8F25752108AQ41980286-95B43BE1-47B4-433D-AAAB-7BBD326730CAQ43100463-C555EE83-EBE4-4637-B80D-3FDD796E9CE9Q47565847-E18BBC24-E5AE-464F-99CB-A20826AB9FD9Q47915660-4E51188C-D5E6-4B44-B26A-2AB6522B911FQ48388778-C7F6E9AA-2983-486E-9686-02B3BD0781B1Q50485670-D7757E44-6DE5-4067-A771-981C6BA7329F
P2860
The treatment of patients at risk of developing Wernicke's encephalopathy in the community.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
The treatment of patients at r ...... cephalopathy in the community.
@ast
The treatment of patients at r ...... cephalopathy in the community.
@en
type
label
The treatment of patients at r ...... cephalopathy in the community.
@ast
The treatment of patients at r ...... cephalopathy in the community.
@en
prefLabel
The treatment of patients at r ...... cephalopathy in the community.
@ast
The treatment of patients at r ...... cephalopathy in the community.
@en
P2860
P356
P1476
The treatment of patients at r ...... cephalopathy in the community.
@en
P2093
Allan D Thomson
E Jane Marshall
P2860
P304
P356
10.1093/ALCALC/AGH250
P577
2005-12-29T00:00:00Z